您的位置:网站名称 研发专利新闻 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

USPTO issues patent to Somaxon's Silenor food effect


Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX), a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office has issued U.S. patent no. 7,915,307, entitled Methods of Improving the Pharmacokinetics of Doxepin....

查看所有的文章内容需要 VIP会员权限 查看


 
点这里复制本页地址发送给您QQ/MSN上的好友

相关文章

USPTO issues Notice of Allowance to Modu
Biotectix acquires Chameleon BioSurfaces
U.S. District Court rules in favor of Wa
US District Court rules against Watson i
USPTO issues Notice of Allowance to Alph
VARI, Gentel Biosciences receive U.S. Pa
Colorcon announces specific details on i
ACT to be awarded broad patent protectio
NephRx receives new U.S. patent for NX00
USPTO grants patent to ULURU's Altrazeal
USPTO grants composition-of-matter paten
USPTO issues patent to Asterand's BioMAP
Medical industry veteran set to play key
Cubist enters license agreement with Tev
Shire files lawsuit against Watson over
USPTO issues notice of allowance to Mirn
EPO Board of Appeal rejects B.Braun pate
Watson confirms patent challenge by Alco
USPTO issues new patent to Onset Medical
Echo awarded method patent for Symphony

相关评论


本文章所属分类:首页 研发专利新闻